Naoto TominagaDivision of Nephrology and Hypertension, Kawasaki Municipal Tama Hospital, Kawasaki, Kanagawa, Japan and Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
SpasovskiG, VanholderR, AllolioB, AnnaneD, BallS, BichetD, et al.; Hyponatraemia Guideline Development Group: Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant29[Suppl 2]: i1–i39, 201410.1093/ndt/gfu040PubMed
DeVitaMV, GardenswartzMH, KoneckyA, ZabetakisPM: Incidence and etiology of hyponatremia in an intensive care unit. Clin Nephrol 34: 163–166, 1990PubMed)| false
BrunsvigPF, OsI, FrederichsenP: Hyponatremi. En retrospektiv studie med henblikk på forekomst, årsak og mortalitet. [Hyponatremia. A retrospective study of occurrence, etiology and mortality] Tidsskr Nor Laegeforen110: 2367–2369, 1990PubMed
BrunsvigPF, OsI, FrederichsenP: Hyponatremi. En retrospektiv studie med henblikk på forekomst, årsak og mortalitet. [Hyponatremia. A retrospective study of occurrence, etiology and mortality] Tidsskr Nor Laegeforen 110: 2367–2369, 1990PubMed)| false
AndersonRJ, ChungHM, KlugeR, SchrierRW: Hyponatremia: A prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med102: 164–168, 1985PubMed
AndersonRJ, ChungHM, KlugeR, SchrierRW: Hyponatremia: A prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 102: 164–168, 1985PubMed)| false
FarrellMJ, ZamarripaF, ShadeR, PhillipsPA, McKinleyM, FoxPT, et al..: Effect of aging on regional cerebral blood flow responses associated with osmotic thirst and its satiation by water drinking: A PET study. Proc Natl Acad Sci U S A105: 382–387, 2008PubMed
FarrellMJ, ZamarripaF, ShadeR, PhillipsPA, McKinleyM, FoxPT, .: Effect of aging on regional cerebral blood flow responses associated with osmotic thirst and its satiation by water drinking: A PET study. Proc Natl Acad Sci U S A 105: 382–387, 2008PubMed)| false
JuulKV, BichetDG, NielsenS, NørgaardJP: The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors. Am J Physiol Renal Physiol306: F931–F940, 2014PubMed
JuulKV, BichetDG, NielsenS, NørgaardJP: The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors. Am J Physiol Renal Physiol 306: F931–F940, 2014PubMed)| false
DunnFL, BrennanTJ, NelsonAE, RobertsonGL: The role of blood osmolality and volume in regulating vasopressin secretion in the rat. J Clin Invest52: 3212–3219, 1973PubMed
DunnFL, BrennanTJ, NelsonAE, RobertsonGL: The role of blood osmolality and volume in regulating vasopressin secretion in the rat. J Clin Invest 52: 3212–3219, 1973PubMed)| false
GheorgheG, IlieM, BungauS, StoianAMP, BacalbasaN, DiaconuCC: Is there a relationship between COVID-19 and hyponatremia?Medicina (Kaunas)57: 55, 2021PubMed
GheorgheG, IlieM, BungauS, StoianAMP, BacalbasaN, DiaconuCC: Is there a relationship between COVID-19 and hyponatremia?Medicina (Kaunas) 57: 55, 2021PubMed)| false
SwartRM, HoornEJ, BetjesMG, ZietseR: Hyponatremia and inflammation: The emerging role of interleukin-6 in osmoregulation. Nephron, Physiol118: 45–51, 2011PubMed
SwartRM, HoornEJ, BetjesMG, ZietseR: Hyponatremia and inflammation: The emerging role of interleukin-6 in osmoregulation. Nephron, Physiol 118: 45–51, 2011PubMed)| false
EdelmanIS, LeibmanJ, O’MearaMP, BirkenfeldLW: Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest37: 1236–1256, 1958PubMed
EdelmanIS, LeibmanJ, O’MearaMP, BirkenfeldLW: Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest 37: 1236–1256, 1958PubMed)| false
AviramA, PfauA, CzaczkesJW, UllmannTD: Hyperosmolality with hyponatremia, caused by inappropriate administration of mannitol. Am J Med42: 648–650, 1967PubMed
AviramA, PfauA, CzaczkesJW, UllmannTD: Hyperosmolality with hyponatremia, caused by inappropriate administration of mannitol. Am J Med 42: 648–650, 1967PubMed)| false
DesmondJ: Serum osmolality and plasma electrolytes in patients who develop dilutional hyponatremia during transurethral resection. Can J Surg13: 116–121, 1970PubMed
DesmondJ: Serum osmolality and plasma electrolytes in patients who develop dilutional hyponatremia during transurethral resection. Can J Surg 13: 116–121, 1970PubMed)| false
LevinA, KlassenJ, HalperinML: Challenging consults: Application of principles of physiology and biochemistry to the bedside. Osmotic diuresis: The importance of counting the number of osmoles excreted. Clin Invest Med18: 401–405, 1995PubMed
LevinA, KlassenJ, HalperinML: Challenging consults: Application of principles of physiology and biochemistry to the bedside. Osmotic diuresis: The importance of counting the number of osmoles excreted. Clin Invest Med 18: 401–405, 1995PubMed)| false
BraunMM, BarstowCH, PyzochaNJ: Diagnosis and management of sodium disorders: Hyponatremia and hypernatremia. Am Fam Physician 91: 299–307, 2015PubMed)| false
FenskeW, StörkS, KoschkerAC, BlechschmidtA, LorenzD, WortmannS, et al..: Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. J Clin Endocrinol Metab93: 2991–2997, 2008PubMed
SchwartzWB, BennettW, CurelopS, BartterFC: A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med23: 529–542, 1957PubMed
SchwartzWB, BennettW, CurelopS, BartterFC: A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 23: 529–542, 1957PubMed)| false
SchwartzWB, BennettW, CurelopS, BartterFC: A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. 1957. J Am Soc Nephrol12: 2860–2870, 2001PubMed
SchwartzWB, BennettW, CurelopS, BartterFC: A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. 1957. J Am Soc Nephrol 12: 2860–2870, 2001PubMed)| false
GeorgeJC, ZafarW, BucaloiuID, ChangAR: Risk factors and outcomes of rapid correction of severe hyponatremia. Clin J Am Soc Nephrol13: 984–992, 2018PubMed
GeorgeJC, ZafarW, BucaloiuID, ChangAR: Risk factors and outcomes of rapid correction of severe hyponatremia. Clin J Am Soc Nephrol 13: 984–992, 2018PubMed)| false
DecauxG, VandergheynstF, BoukoY, ParmaJ, VassartG, VilainC: Nephrogenic syndrome of inappropriate antidiuresis in adults: High phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol18: 606–612, 2007PubMed
DecauxG, VandergheynstF, BoukoY, ParmaJ, VassartG, VilainC: Nephrogenic syndrome of inappropriate antidiuresis in adults: High phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol 18: 606–612, 2007PubMed)| false
ByattCM, MillardPH, LevinGE: Diuretics and electrolyte disturbances in 1000 consecutive geriatric admissions. J R Soc Med 83: 704–708, 1990PubMed)| false
BarberJ, McKeeverTM, McDowellSE, ClaytonJA, FernerRE, GordonRD, et al..: A systematic review and meta-analysis of thiazide-induced hyponatraemia: Time to reconsider electrolyte monitoring regimens after thiazide initiation?Br J Clin Pharmacol79: 566–577, 2015PubMed
Barroso-SousaR, BarryWT, Garrido-CastroAC, HodiFS, MinL, KropIE, et al..: Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: A systematic review and meta-analysis. JAMA Oncol4: 173–182, 2018PubMed
Barroso-SousaR, BarryWT, Garrido-CastroAC, HodiFS, MinL, KropIE, .: Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: A systematic review and meta-analysis. JAMA Oncol 4: 173–182, 2018PubMed)| false
CaturegliP, Di DalmaziG, LombardiM, GrossoF, LarmanHB, LarmanT, et al..: Hypophysitis secondary to cytotoxic T-lymphocyte-associated protein 4 blockade: Insights into pathogenesis from an autopsy series. Am J Pathol186: 3225–3235, 2016PubMed
CaturegliP, Di DalmaziG, LombardiM, GrossoF, LarmanHB, LarmanT, .: Hypophysitis secondary to cytotoxic T-lymphocyte-associated protein 4 blockade: Insights into pathogenesis from an autopsy series. Am J Pathol 186: 3225–3235, 2016PubMed)| false
FajeA, ReynoldsK, ZubiriL, LawrenceD, CohenJV, SullivanRJ, et al..: Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis. Eur J Endocrinol181: 211–219, 2019PubMed
YatagaiT, KusakaI, NakamuraT, NagasakaS, HondaK, IshibashiS, et al..: Close association of severe hyponatremia with exaggerated release of arginine vasopressin in elderly subjects with secondary adrenal insufficiency. Eur J Endocrinol148: 221–226, 2003PubMed
YatagaiT, KusakaI, NakamuraT, NagasakaS, HondaK, IshibashiS, .: Close association of severe hyponatremia with exaggerated release of arginine vasopressin in elderly subjects with secondary adrenal insufficiency. Eur J Endocrinol 148: 221–226, 2003PubMed)| false
DineenR, HannonMJ, ThompsonCJ: Hyponatremia and Hypernatremia. In: Endocrinology: Adult and Pediatric7th Ed., edited by J. Larry Jameson, Leslie J De Groot, David M. de Kretser, Linda C. Giudice, Ashley B. Grossman, Shlomo Melmed, John T. Potts, and Gordon C. Weir, J. Larry Jameson, Leslie J De Groot, David M. de Kretser, Linda C. Giudice, Ashley B. Grossman, Shlomo Melmed, John T. Potts, and Gordon C. Weir, Philadelphia, Elsevier, 2016, pp 1953–1962
DineenR, HannonMJ, ThompsonCJ: Hyponatremia and Hypernatremia. In: Endocrinology: Adult and Pediatric 7th Ed., edited by J. Larry Jameson, Leslie J De Groot, David M. de Kretser, Linda C. Giudice, Ashley B. Grossman, Shlomo Melmed, John T. Potts, and Gordon C. Weir, J. Larry Jameson, Leslie J De Groot, David M. de Kretser, Linda C. Giudice, Ashley B. Grossman, Shlomo Melmed, John T. Potts, and Gordon C. Weir, Philadelphia, Elsevier, 2016, pp 1953–1962)| false
VerbalisJG: Adaptation to acute and chronic hyponatremia: Implications for symptomatology, diagnosis, and therapy. Semin Nephrol 18: 3–19, 1998PubMed)| false
RenneboogB, MuschW, VandemergelX, MantoMU, DecauxG.Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med119: e1–e8, 2006PubMed
RenneboogB, MuschW, VandemergelX, MantoMU, DecauxG.Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 119: e1–e8, 2006PubMed)| false
HoornEJ, RivadeneiraF, van MeursJB, ZiereG, StrickerBH, HofmanA, et al.: Mild hyponatremia as a risk factor for fractures: The Rotterdam Study. J Bone Miner Res26: 1822–1828, 2011PubMed
HoornEJ, RivadeneiraF, van MeursJB, ZiereG, StrickerBH, HofmanA, : Mild hyponatremia as a risk factor for fractures: The Rotterdam Study. J Bone Miner Res 26: 1822–1828, 2011PubMed)| false
BerghmansT, PaesmansM, BodyJJ: A prospective study on hyponatraemia in medical cancer patients: Epidemiology, aetiology and differential diagnosis. Support Care Cancer8: 192–197, 2000PubMed
BerghmansT, PaesmansM, BodyJJ: A prospective study on hyponatraemia in medical cancer patients: Epidemiology, aetiology and differential diagnosis. Support Care Cancer 8: 192–197, 2000PubMed)| false
GreenbergA, VerbalisJG, AminAN, BurstVR, ChiodoJA3rd, ChiongJR, et al.: Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int88: 167–177, 2015PubMed
GreenbergA, VerbalisJG, AminAN, BurstVR, ChiodoJA3rd, ChiongJR, : Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int 88: 167–177, 2015PubMed)| false
BattisonC, AndrewsPJ, GrahamC, PettyT: Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med33: 196–202, discussion 257–258, 2005PubMed
BattisonC, AndrewsPJ, GrahamC, PettyT: Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 33: 196–202, discussion 257–258, 2005PubMed)| false
GarrahyA, DineenR, HannonAM, CuestaM, TormeyW, SherlockM, et al.: Continuous versus bolus infusion of hypertonic saline in the treatment of symptomatic hyponatremia caused by SIAD. J Clin Endocrinol Metab104: 3595–3602, 2019PubMed
BaekSH, JoYH, AhnS, Medina-LiabresK, OhYK, LeeJB, et al.: Risk of overcorrection in rapid intermittent bolus vs slow continuous infusion therapies of hypertonic saline for patients with symptomatic hyponatremia: The SALSA randomized clinical trial. JAMA Intern Med181: 81–92, 2021PubMed
BaekSH, JoYH, AhnS, Medina-LiabresK, OhYK, LeeJB, : Risk of overcorrection in rapid intermittent bolus vs slow continuous infusion therapies of hypertonic saline for patients with symptomatic hyponatremia: The SALSA randomized clinical trial. JAMA Intern Med 181: 81–92, 2021PubMed)| false
AdamsRD, VictorM, MancallEL: Central pontine myelinolysis: A hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry81: 154–172, 1959PubMed
AdamsRD, VictorM, MancallEL: Central pontine myelinolysis: A hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry 81: 154–172, 1959PubMed)| false
BerlT, RastegarA: A patient with severe hyponatremia and hypokalemia: Osmotic demyelination following potassium repletion. Am J Kidney Dis55: 742–748, 2010PubMed
BerlT, RastegarA: A patient with severe hyponatremia and hypokalemia: Osmotic demyelination following potassium repletion. Am J Kidney Dis 55: 742–748, 2010PubMed)| false
SoodL, SternsRH, HixJK, SilverSM, ChenL: Hypertonic saline and desmopressin: A simple strategy for safe correction of severe hyponatremia. Am J Kidney Dis61: 571–578, 2013PubMed
SoodL, SternsRH, HixJK, SilverSM, ChenL: Hypertonic saline and desmopressin: A simple strategy for safe correction of severe hyponatremia. Am J Kidney Dis 61: 571–578, 2013PubMed)| false
VerbalisJG, GreenbergA, BurstV, HaymannJP, JohannssonG, PeriA, PochE, ChiodoJA3rd, DaveJ.Diagnosing and treating the syndrome of inappropriate antidiuretic hormone secretion. Am J Med 129: e9-537, 2016PubMed)| false
HantmanD, RossierB, ZohlmanR, SchrierR: Rapid correction of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. An alternative treatment to hypertonic saline. Ann Intern Med78: 870–875, 1973PubMed
HantmanD, RossierB, ZohlmanR, SchrierR: Rapid correction of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. An alternative treatment to hypertonic saline. Ann Intern Med 78: 870–875, 1973PubMed)| false
SoupartA, CoffernilsM, CouturierB, Gankam-KengneF, DecauxG: Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH. Clin J Am Soc Nephrol7: 742–747, 2012PubMed
SoupartA, CoffernilsM, CouturierB, Gankam-KengneF, DecauxG: Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH. Clin J Am Soc Nephrol 7: 742–747, 2012PubMed)| false
KrisanapanP, VongsanimS, Pin-OnP, RuengornC, NoppakunK: Efficacy of furosemide, oral sodium chloride, and fluid restriction for treatment of syndrome of inappropriate antidiuresis (SIAD): An open-label randomized controlled study (The EFFUSE-FLUID Trial). Am J Kidney Dis76: 203–212, 2020PubMed
KrisanapanP, VongsanimS, Pin-OnP, RuengornC, NoppakunK: Efficacy of furosemide, oral sodium chloride, and fluid restriction for treatment of syndrome of inappropriate antidiuresis (SIAD): An open-label randomized controlled study (The EFFUSE-FLUID Trial). Am J Kidney Dis 76: 203–212, 2020PubMed)| false
YamamuraY, NakamuraS, ItohS, HiranoT, OnogawaT, YamashitaT, et al.: OPC-41061, a highly potent human vasopressin V2-receptor antagonist: Pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther287: 860–867, 1998PubMed
SchrierRW, GrossP, GheorghiadeM, BerlT, VerbalisJG, CzerwiecFS, et al.; SALT Investigators: Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med355: 2099–2112, 2006PubMed
BerlT, Quittnat-PelletierF, VerbalisJG, SchrierRW, BichetDG, OuyangJ, et al.; SALTWATER Investigators: Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol21: 705–712, 2010PubMed
DecauxG, AndresC, Gankam KengneF, SoupartA: Treatment of euvolemic hyponatremia in the intensive care unit by urea. Crit Care 14: R184, 2010PubMed)| false
Rondon-BerriosH, TandukarS, MorMK, RayEC, BenderFH, KleymanTR, et al.: Urea for the treatment of hyponatremia. Clin J Am Soc Nephrol13: 1627–1632, 2018PubMed
RefardtJ, ImberC, SailerCO, JeanlozN, PotassoL, KutzA, et al.: A randomized trial of empagliflozin to increase plasma sodium levels in patients with the syndrome of inappropriate antidiuresis. J Am Soc Nephrol31: 615–624, 2020PubMed
RefardtJ, ImberC, SailerCO, JeanlozN, PotassoL, KutzA, : A randomized trial of empagliflozin to increase plasma sodium levels in patients with the syndrome of inappropriate antidiuresis. J Am Soc Nephrol 31: 615–624, 2020PubMed)| false